FI83659C - Foerfarande foer framstaellning av terapeutiskt anvaendbara o-glykosidfoereningar och mellanprodukter. - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara o-glykosidfoereningar och mellanprodukter. Download PDF

Info

Publication number
FI83659C
FI83659C FI863703A FI863703A FI83659C FI 83659 C FI83659 C FI 83659C FI 863703 A FI863703 A FI 863703A FI 863703 A FI863703 A FI 863703A FI 83659 C FI83659 C FI 83659C
Authority
FI
Finland
Prior art keywords
cooch3
formula
group
oac
sugar
Prior art date
Application number
FI863703A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI863703A (fi
FI83659B (fi
FI863703A0 (fi
Inventor
Hans Goeran Magnusson
Torbjoern Frejd
Original Assignee
Symbicom Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbicom Ab filed Critical Symbicom Ab
Publication of FI863703A publication Critical patent/FI863703A/fi
Publication of FI863703A0 publication Critical patent/FI863703A0/fi
Publication of FI83659B publication Critical patent/FI83659B/fi
Application granted granted Critical
Publication of FI83659C publication Critical patent/FI83659C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
FI863703A 1985-01-14 1986-09-12 Foerfarande foer framstaellning av terapeutiskt anvaendbara o-glykosidfoereningar och mellanprodukter. FI83659C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK17685 1985-01-14
DK17685A DK17685D0 (da) 1985-01-14 1985-01-14 Glycosidderivater
PCT/DK1986/000006 WO1986004065A1 (fr) 1985-01-14 1986-01-13 Derives glucosidiques
DK8600006 1986-01-13

Publications (4)

Publication Number Publication Date
FI863703A FI863703A (fi) 1986-09-12
FI863703A0 FI863703A0 (fi) 1986-09-12
FI83659B FI83659B (fi) 1991-04-30
FI83659C true FI83659C (fi) 1991-08-12

Family

ID=8090628

Family Applications (1)

Application Number Title Priority Date Filing Date
FI863703A FI83659C (fi) 1985-01-14 1986-09-12 Foerfarande foer framstaellning av terapeutiskt anvaendbara o-glykosidfoereningar och mellanprodukter.

Country Status (13)

Country Link
US (1) US4868289A (fr)
EP (1) EP0208749B1 (fr)
JP (1) JP2510176B2 (fr)
CN (1) CN1022687C (fr)
AU (1) AU588854B2 (fr)
CA (1) CA1316170C (fr)
DE (1) DE3663029D1 (fr)
DK (1) DK17685D0 (fr)
FI (1) FI83659C (fr)
IE (1) IE58778B1 (fr)
IL (1) IL77602A (fr)
NO (1) NO166865C (fr)
WO (1) WO1986004065A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314642A (en) * 1984-11-27 1994-05-24 Igen, Inc. Interaction system comprising a surfactant-stabilized aqueous phase containing an antibody fragment
DK17785D0 (da) * 1985-01-14 1985-01-14 Hans Goeran Magnusson Propanolderivater
ZA872203B (en) * 1986-04-28 1988-02-24 New York Blood Center Inc Complex immunogen containing synthetic peptides
US5169636A (en) * 1988-03-17 1992-12-08 Nippon Fine Chemical Co., Ltd. Liposomes
DK455088D0 (da) * 1988-08-12 1988-08-12 Symbicom Ab Syntetiske receptoranaloger
JP2694282B2 (ja) * 1988-09-02 1997-12-24 大塚製薬株式会社 グリコシル化法
US5141925A (en) * 1990-04-23 1992-08-25 Trustees Of Tufts College Vivo methods for treating coccidiosis
US5241072A (en) * 1990-05-25 1993-08-31 Genzyne Corporation Oligosaccharide oxazolines, oligosaccharide conjugates and methods of preparation thereof
US5846951A (en) * 1991-06-06 1998-12-08 The School Of Pharmacy, University Of London Pharmaceutical compositions
GB9112212D0 (en) * 1991-06-06 1991-07-24 Gregoriadis Gregory Pharmaceutical compositions
EP0531256B1 (fr) * 1991-09-04 1997-04-23 Novartis AG Méthode pour la préparation des glycosides
US5409902A (en) * 1991-12-31 1995-04-25 Lever Brothers Company Oral hygiene compositions containing glyceroglycolipids as antiplaque compounds
DE69316754T2 (de) * 1992-06-01 1998-07-16 Biomembrane Inst Schrittweise entfernung von monosacchariden vom reduzierenden ende von oligosacchariden und verwendungen davon
EP0601417A3 (fr) * 1992-12-11 1998-07-01 Hoechst Aktiengesellschaft Physiologiquement compatible et dégradable bloques de récepteur d'hydrate de carbone à base de polymère, procédé de leur préparation et leur utilisation
WO1994020116A1 (fr) * 1993-03-10 1994-09-15 University Of Alabama Research Foundation Amorces artificielles pour la synthese du glycogene
US5661130A (en) * 1993-06-24 1997-08-26 The Uab Research Foundation Absorption enhancers for drug administration
DK76193D0 (da) * 1993-06-25 1993-06-25 Astra Ab Kulhydratderivater
US5891862A (en) * 1996-03-15 1999-04-06 Geltex Pharmaceuticals, Inc. Polyvalent polymers for the treatment of rotavirus infection
US5700458A (en) * 1996-09-20 1997-12-23 Geltex Pharmaceuticals Inc. Acid-functionalized saccharides as polyvalent anti-infectives
US5973128A (en) * 1996-11-22 1999-10-26 The Hospital For Sick Children Research And Development Lp Glycolipid mimics and methods of use thereof
DE19728900A1 (de) * 1997-07-07 1999-01-14 Henkel Kgaa Hydrophile Glykoside
FI20010118A (fi) * 2001-01-19 2002-07-20 Carbion Oy Uudet helicobacter pylori reseptorit ja niiden käyttö
US20050096446A1 (en) * 2003-10-29 2005-05-05 Council Of Scientific And Industrial Tri-block copolymers and a process for the preparation of the same
US8268791B2 (en) * 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US20090047347A1 (en) * 2005-07-29 2009-02-19 Aegis Therapeutics, Inc. Compositions for Drug Administration
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
US7524510B2 (en) * 2005-02-23 2009-04-28 The Uab Research Foundation Alkyl-glycoside enhanced vaccination
US8226949B2 (en) 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
JP4636041B2 (ja) 2007-03-14 2011-02-23 日立工機株式会社 打込機
ES2586032T3 (es) 2008-03-28 2016-10-11 Hale Biopharma Ventures, Llc Administración de composiciones de benzodiazepinas
US8440631B2 (en) 2008-12-22 2013-05-14 Aegis Therapeutics, Llc Compositions for drug administration
WO2012174158A2 (fr) 2011-06-14 2012-12-20 Hale Biopharma Ventures, Llc Administration de benzodiazépine

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2252706A (en) * 1938-10-20 1941-08-19 Squibb & Sons Inc Haloalkyl polyacyl glycosides
US3843626A (en) * 1968-12-31 1974-10-22 Smithkline Corp Anti-inflammatory compositions containing acylated-b-d-glucopyranosides and methods of using them
US3939146A (en) * 1973-03-01 1976-02-17 Strategic Medical Research Corporation Novel ethereal monosubstitutions of monosaccharide derivatives
US3939145A (en) * 1973-03-01 1976-02-17 Strategic Medical Research Corporation Novel ethereally monosubstituted monosaccharides
US3965262A (en) * 1973-03-01 1976-06-22 Strategic Medical Research Corporation Method of enhancing learning and/or memory in warm blooded animals
US4016261A (en) * 1973-03-01 1977-04-05 Strategic Medical Research Corporation Therapeutic composition and method of therapeutically treating warm blooded animals therewith
US4017608A (en) * 1973-12-14 1977-04-12 Strategic Medical Research Corporation Therapeutic composition and method of therapeutically treating warm blooded animals therewith
US4056322A (en) * 1973-12-14 1977-11-01 Strategic Medical Research Corporation Preparation of ethers of monosaccharides
AU1227276A (en) * 1975-03-28 1977-09-29 Strategic Medical Res Corp Ethers of monosaccarides
GB1544908A (en) * 1975-07-08 1979-04-25 Chembiomed Ltd Artificial oligosaccharide antigenic determinants
FR2509313A1 (fr) * 1981-07-08 1983-01-14 Choay Sa Derives de 3-fucosyl-n-acetyl lactosamine, leur preparation et leurs applications biologiques
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
SE8203925D0 (sv) * 1982-06-23 1982-06-23 Svenska Sockerfabriks Ab New and novel glycosides, glycoconjugates and processes for their preparation
US4557931A (en) * 1982-12-02 1985-12-10 Regents Of The University Of California Antigenic compositions and methods for using same
SE8301609D0 (sv) * 1983-03-23 1983-03-23 Svenska Sockerfabriks Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling

Also Published As

Publication number Publication date
IE58778B1 (en) 1993-11-17
DE3663029D1 (en) 1989-06-01
FI863703A (fi) 1986-09-12
EP0208749B1 (fr) 1989-04-26
WO1986004065A1 (fr) 1986-07-17
JP2510176B2 (ja) 1996-06-26
NO166865C (no) 1991-09-11
AU588854B2 (en) 1989-09-28
AU5351586A (en) 1986-07-29
FI83659B (fi) 1991-04-30
CN86100178A (zh) 1987-07-15
CA1316170C (fr) 1993-04-13
CN1022687C (zh) 1993-11-10
NO166865B (no) 1991-06-03
IL77602A (en) 1993-05-13
NO863645L (no) 1986-11-13
NO863645D0 (no) 1986-09-12
US4868289A (en) 1989-09-19
JPS62502258A (ja) 1987-09-03
IE860077L (en) 1986-07-14
DK17685D0 (da) 1985-01-14
FI863703A0 (fi) 1986-09-12
EP0208749A1 (fr) 1987-01-21

Similar Documents

Publication Publication Date Title
FI83659C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara o-glykosidfoereningar och mellanprodukter.
US4859769A (en) Antiviral agents
US5591835A (en) Substituted lactose derivatives
FI78707C (fi) Nya glykosider och glykokonjugater och foerfarande foer deras framstaellning.
Aly et al. Synthesis of lacto-N-neotetraose and lacto-N-tetraose using the dimethylmaleoyl group as amino protective group
EP0089939A1 (fr) Compositions à emploi thérapeutique ou diagnostique contenant des oligosaccharides
WO1990001488A1 (fr) Analogues de recepteurs synthetiques
AU678373B2 (en) Substituted lactose derivatives as cell adhesion inhibitors
AU674293B2 (en) Ganglioside analogs
Lowary et al. Synthesis of a pentasaccharide epitope for the investigation of carbohydrate-protein interactions
WO1996035700A1 (fr) Saccharopeptides et derives
US20170320914A1 (en) Multivalent ligand-lipid constructs
Vermeer et al. Synthesis and conjugation of oligosaccharide fragments related to the immunologically reactive part of the circulating anodic antigen of the parasite Schistosoma mansoni
Sarkar et al. Synthesis and glycosaminoglycan priming activity of three disaccharides related to the linkage region tetrasaccharide of proteoglycans
Song et al. Structure of novel gangliosides, deaminated neuraminic acid (KDN) containing glycosphingolipids, isolated from rainbow trout ovarian fluid
EP0830365B1 (fr) Analogues kojibiosides modifies
Subramani et al. Demystifying a hexuronic acid ligand that recognizes Toxoplasma gondii and blocks its invasion into host cells
EP0051593A1 (fr) Isolation d'hydrates de carbone a partir de tissus cellulaires
WO1996034609A1 (fr) Myeloglycan
John Structural elucidation of outer membrane lipooligosaccharides from Neisseria gonorrhoeae
US20030064956A1 (en) Myeloglycan
Cato Chemical synthesis of the O-linked oligosaccharide of P-Selectin Glycoprotein Ligand-1
Yang Synthetic Ligands for L-selectin and for B-cell Receptors
Shaikh Tools to unravel secrets of glycobiology: synthesis of glycocluster peptides and functional oOligosaccharides
Reimer The Synthesis of Oligosaccharides Corresponding to the Cell-wall Polysaccharides of the (beta)-hemolytic Streptocci Group A

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: SYMBICOM AKTIEBOLAG